Literature DB >> 17509565

Impaired mitochondrial Ca2+ homeostasis in respiratory chain-deficient cells but efficient compensation of energetic disadvantage by enhanced anaerobic glycolysis due to low ATP steady state levels.

Jürgen-Christoph von Kleist-Retzow1, Hue-Tran Hornig-Do, Matthias Schauen, Sabrina Eckertz, Tuan Anh Duong Dinh, Frank Stassen, Nadine Lottmann, Maria Bust, Bistra Galunska, Klaus Wielckens, Wolfgang Hein, Joseph Beuth, Jan-Matthias Braun, Jürgen H Fischer, Vladimir Y Ganitkevich, Katharina Maniura-Weber, Rudolf J Wiesner.   

Abstract

Energy-producing pathways, adenine nucleotide levels, oxidative stress response and Ca(2+) homeostasis were investigated in cybrid cells incorporating two pathogenic mitochondrial DNA point mutations, 3243A>G and 3302A>G in tRNA(Leu(UUR)), as well as Rho(0) cells and compared to their parental 143B osteosarcoma cell line. All cells suffering from a severe respiratory chain deficiency were able to proliferate as fast as controls. The major defect in oxidative phosphorylation was efficiently compensated by a rise in anaerobic glycolysis, so that the total ATP production rate was preserved. This enhancement of glycolysis was enabled by a considerable decrease of cellular total adenine nucleotide pools and a concomitant shift in the AMP+ADP/ATP ratios, while the energy charge potential was still in the normal range. Further important consequences were an increased production of superoxide which, however, was neither escorted by major changes in the antioxidative defence systems nor was it leading to substantial oxidative damage. Most interestingly, the lowered mitochondrial membrane potential led to a disturbed intramitochondrial calcium homeostasis, which most likely is a major pathomechanism in mitochondrial diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17509565     DOI: 10.1016/j.yexcr.2007.04.015

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  20 in total

1.  Mitochondrial DNA mutations affect calcium handling in differentiated neurons.

Authors:  Andrew J Trevelyan; Denise M Kirby; Tora K Smulders-Srinivasan; Marco Nooteboom; Rebeca Acin-Perez; José Antonio Enriquez; Miles A Whittington; Robert N Lightowlers; Doug M Turnbull
Journal:  Brain       Date:  2010-03-05       Impact factor: 13.501

2.  Mitochondrial DNA sequence variation in multiple sclerosis.

Authors:  Gregory J Tranah; Adam Santaniello; Stacy J Caillier; Sandra D'Alfonso; Filippo Martinelli Boneschi; Stephen L Hauser; Jorge R Oksenberg
Journal:  Neurology       Date:  2015-07-01       Impact factor: 9.910

3.  Complete failure of insulin-transmitted signaling, but not obesity-induced insulin resistance, impairs respiratory chain function in muscle.

Authors:  A Franko; J C von Kleist-Retzow; M Böse; C Sanchez-Lasheras; S Brodesser; O Krut; W S Kunz; D Wiedermann; M Hoehn; O Stöhr; L Moll; S Freude; W Krone; M Schubert; R J Wiesner
Journal:  J Mol Med (Berl)       Date:  2012-03-13       Impact factor: 4.599

Review 4.  Somatic Mutations in Cardiovascular Disease.

Authors:  J Brett Heimlich; Alexander G Bick
Journal:  Circ Res       Date:  2022-01-07       Impact factor: 17.367

Review 5.  Review: Mitochondria and disease progression in multiple sclerosis.

Authors:  D Mahad; H Lassmann; D Turnbull
Journal:  Neuropathol Appl Neurobiol       Date:  2008-12       Impact factor: 8.090

Review 6.  Mitochondrial disorders as windows into an ancient organelle.

Authors:  Scott B Vafai; Vamsi K Mootha
Journal:  Nature       Date:  2012-11-15       Impact factor: 49.962

7.  Relationship of cerebrospinal fluid glucose metabolites to MRI deep white matter hyperintensities and treatment resistance in bipolar disorder patients.

Authors:  William T Regenold; K Calvin Hisley; Pornima Phatak; Christopher M Marano; Abraham Obuchowski; David M Lefkowitz; Amritpal Sassan; Sameer Ohri; Tony L Phillips; Narveen Dosanjh; Robert R Conley; Rao Gullapalli
Journal:  Bipolar Disord       Date:  2008-11       Impact factor: 6.744

8.  Bezielle selectively targets mitochondria of cancer cells to inhibit glycolysis and OXPHOS.

Authors:  Vivian Chen; Richard E Staub; Sylvia Fong; Mary Tagliaferri; Isaac Cohen; Emma Shtivelman
Journal:  PLoS One       Date:  2012-02-03       Impact factor: 3.240

9.  Mitochondrial changes within axons in multiple sclerosis.

Authors:  Don J Mahad; Iryna Ziabreva; Graham Campbell; Nichola Lax; Katherine White; Peter S Hanson; Hans Lassmann; Douglass M Turnbull
Journal:  Brain       Date:  2009-03-17       Impact factor: 13.501

10.  Cytochrome c oxidase deficiency accelerates mitochondrial apoptosis by activating ceramide synthase 6.

Authors:  S Schüll; S D Günther; S Brodesser; J M Seeger; B Tosetti; K Wiegmann; C Pongratz; F Diaz; A Witt; M Andree; K Brinkmann; M Krönke; R J Wiesner; H Kashkar
Journal:  Cell Death Dis       Date:  2015-03-12       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.